Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on January 02, 2026.
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics Limited held a board meeting on January 02, 2026 (2:00 PM to 4:00 PM) and approved the appointment of Mr. Ganesh Suresh Potdar as an Additional Director in the capacity of Executive Director and Occupier of all units of the company. His term runs from January 02, 2026 to January 01, 2030. The appointment is subject to shareholder approval at the next general meeting or postal ballot. Mr. Potdar is an Indian national, born on 27.02.1975, an under-graduate by qualification, and currently holds no other listed company directorships, committee memberships, or shares in the company. His expertise is described in general terms around business operations, banking processes, and financial coordination.
This is a routine board-level appointment with no disclosed shareholding by the new director. The appointment is subject to shareholder approval, so retail investors may have a say at the upcoming general meeting or postal ballot. Material impact on stock price is unlikely unless shareholders reject the appointment.